← Open Payments lookup

ADAM CHERRY: Open Payments

NPI 1770805673 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,518 in 95 payments from 18 companies in 2025. Trend: 2023 $1,189 · 2024 $5,458 · 2025 $3,518

Food & beverage: $2,078Consulting: $1,440
CompanyPaymentsAmount
BioCryst Pharmaceuticals, Inc.1$1,428
AstraZeneca Pharmaceuticals LP21$503
CSL Behring17$271
Takeda Pharmaceuticals U.S.A., Inc.13$258
Novartis Pharmaceuticals Corporation9$240
GlaxoSmithKline, LLC.9$194
Amgen Inc.7$177
Pharming Healthcare, Inc.4$92
Regeneron Healthcare Solutions, Inc.3$76
BioCryst US Sales Co., LLC2$50

Products named: ORLADEYO, TEZSPIRE, Hizentra, CUVITRU, AIRSUPRA, Rhapsido, NUCALA, RUCONEST.

Industry payments across WA — which companies pay providers there.